Nautilus Biotechnology, Inc. (NAUT)

NASDAQ: NAUT · IEX Real-Time Price · USD

2.490

+0.130 (5.51%)

At close: Apr 26, 2024, 4:00 PM

2.460

-0.030 (-1.20%)

After-hours: Apr 26, 2024, 5:48 PM EDT

Nautilus Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	28.9	25.95	21.15	3.31	1.62
Research & Development	47.25	37.67	29.35	12.43	8.49
Operating Expenses	76.15	63.62	50.5	15.74	10.11
Operating Income	-76.15	-63.62	-50.5	-15.74	-10.11
Other Expense / Income	-12.48	-5.69	-0.18	-0.13	-0.49
Pretax Income	-63.68	-57.92	-50.32	-15.62	-9.62
Net Income	-63.68	-57.92	-50.32	-15.62	-9.62
Shares Outstanding (Basic)	125	125	84	29	6
Shares Outstanding (Diluted)	125	125	84	29	6
Shares Change	0.26%	47.51%	190.36%	379.48%	-
EPS (Basic)	-0.51	-0.46	-0.60	-0.54	-1.59
EPS (Diluted)	-0.51	-0.46	-0.60	-0.54	-1.59
Free Cash Flow	-54.15	-48.13	-41.51	-14.92	-10.59
Free Cash Flow Per Share	-0.43	-0.39	-0.49	-0.51	-1.75
EBITDA	-57.97	-54.51	-47.47	-13.27	-9.07
Depreciation & Amortization	5.71	3.42	2.84	2.35	0.55
EBIT	-63.68	-57.92	-50.32	-15.62	-9.62

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).